Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Tlr9-Based Immunotherapy for the Treatment of Allergic Diseases Publisher Pubmed



Farrokhi S1 ; Abbasirad N1 ; Movahed A2 ; Khazaei HA3 ; Pishjoo M4 ; Rezaei N5
Authors

Source: Immunotherapy Published:2017


Abstract

Toll-like receptors (TLRs), a family of pattern recognition receptors expressed on many cell types of innate immunity, recognize the pathogen-associated molecular patterns of microbes. The hygiene hypothesis suggests that a reduced microbial exposure in early childhood increases the susceptibility to allergic diseases due to deviation in development of the immune system. TLRs are key roles in the right and healthy direction of adaptive immunity with the induction of T-helper 2 toward Th1 immune responses and regulatory T cells. TLR ligand CpG-ODN-based immunomodulation is independent of allergen and it mainly affects innate immune system. While, CpG-oligodeoxynucleotide-based vaccination is allergen specific and induces adaptive immune system. The use of agonists of TLR9 in two distinct strategies of immunotherapy, immunomodulation and vaccination, could be presented as the curative method for the treatment of allergic diseases. © 2017 Future Medicine Ltd.
Other Related Docs
8. Defects in Innate Immunity: Receptors and Signaling Components, Encyclopedia of Infection and Immunity (2022)
11. Role of Toll-Like Receptor 4 in Diabetic Retinopathy, Pharmacological Research (2022)